News

Sarepta’s Risky Gamble: Gene Therapy Stays on Market Despite FDA Request
The FDA called for Sarepta Therapeutics to stop shipping its muscular dystrophy gene therapy, but the company said no.
Health and Me on MSN2h
"Obsolete And Unnecessary": FDA Set To Revoke 52 Nutrition And Labeling Rules
The FDA plans to revoke 52 outdated nutrition and labeling regulations to streamline food industry standards, citing them as ...
National Law Review4h
FDA Calls on Infant and Children’s Food Brands to Improve Recall Communications
FDA outlines both short-term and long-term goals within the letter. In the short term, FDA plans to create a “centralized, ...
National Law Review4h
FDA Commissioner Marks His First 100 Days
FDA published a press release written by FDA Commissioner Marty Makary that highlighted his efforts to “make food healthier for children and families, accelerate meaningful cures and treatments, and ...
Which companies have agreed to drop artificial food dyes?
(NEXSTAR) — Dozens of companies that make ice cream and frozen dairy desserts announced on Monday that they would remove artificial food dyes from their products by 2028, marking yet another voluntary ...
vornews8h
Sarepta Tells FDA It Won’t Stop Shipments Despite Patient Deaths
Sarepta Therapeutics announced late Friday evening that it will not comply with the Food and Drug Administration's ...
Sarepta tells FDA it won’t halt shipments despite patient deaths
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...
Gene therapy maker Sarepta tells FDA it won’t halt shipments despite patient deaths
Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...